CONTACT US
Home > Inhibitors/Agonists> > Peramivir
Peramivir

Peramivir

  • CAT Number: I012304
  • CAS Number: 229614-55-5
  • Molecular Formula: C15-H28-N4-O4
  • Molecular Weight: 328.41
  • Purity: ≥95%
Inquiry Now

Peramivir (Cat.No:I012304) is an antiviral medication used for the treatment of influenza A and B viruses. It belongs to the class of neuraminidase inhibitors and works by blocking the activity of the viral neuraminidase enzyme, thereby preventing the release of new viral particles. Peramivir is administered intravenously and offers an alternative treatment option for severe or hospitalized influenza cases.

Catalog Number I012304
CAS Number 229614-55-5
Synonyms

BCX-1812; Rapiacta; RWJ-270201; (1S,2S,3S,4R)-3-[(1S)-1-Acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid

Molecular Formula

C15-H28-N4-O4

Purity 95%
IUPAC Name (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid
InChI 1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12-,13+/m0/s1
InChIKey XRQDFNLINLXZLB-CKIKVBCHSA-N
SMILES CCC(CC)<wbr>[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)<wbr>C(=O)<wbr>O)<wbr>NC(=N)<wbr>N)<wbr>NC(=O)<wbr>C

Request a Quote

Contact Us at MuseChem

We are committed to providing you with reliable, cost-effective solutions for your chemical needs, while ensuring your safety and comfort. Our team of experts is always available to answer your questions and help you navigate the complexities of the chemical industry.

Whether you're looking for a specific product or need help with a custom synthesis project, we're here to help you discover a new world of chemical possibilities. Contact us today to learn more about how we can assist you with all of your chemical needs.

Our goal is to make the process of ordering chemicals as seamless and hassle-free as possible. Let us know how we can assist you, and we'll get back to you as soon as possible. We look forward to hearing from you!